Good-Heart6425
New member
Eli Lilly to offer early access to next-gen obesity drug to some patients#-eli-lilly-to-offer-early-access-to-next-gen-obesity-drug-to-some-patients
REUTERS Aug-03-2026 6:33 p.m. ET By Sneha S K and Deena Beasley
Aug 3 (Reuters) - Eli Lilly (LLY) said on Monday it would allow a limited number of patients to have early access to its experimental obesity drug, retatrutide, before its U.S. FDA approval.
REUTERS Aug-03-2026 6:33 p.m. ET By Sneha S K and Deena Beasley
Aug 3 (Reuters) - Eli Lilly (LLY) said on Monday it would allow a limited number of patients to have early access to its experimental obesity drug, retatrutide, before its U.S. FDA approval.